Madison Investments, an investment advisor, released its fourth-quarter 2025 investor letter for “Madison Small Cap Fund”. A copy of the letter can be downloaded here. The fourth quarter was ...
Amplitude CEO Spenser Skates says most public SaaS companies aren’t transforming fast enough for the AI era. By forcing company-wide AI adoption, accelerating product cycles to weeks not quarters, and ...
Shares of digital analytics platform Amplitude (NASDAQ:AMPL) jumped 12.5% in the afternoon session after the company launched a new series of artificial intelligence (AI) agents designed to ...
InfiniGrow acquisition advances Amplitude’s AI vision by expanding intelligent analytics across marketing and revenue use cases Amplitude, Inc. (Nasdaq: AMPL) has acquired InfiniGrow, an AI marketing ...
Amplitude offers a compelling value opportunity with bargain-basement multiples and a turnaround in fundamentals not yet fully appreciated by the market. AMPL's Q3 beat-and-raise quarter, accelerating ...
Paris-based Amplitude Studios made its mark in 2012 with the 4X turn-based strategy title Endless Space, which led to a number of sequels and spin-offs, including Endless Legend and Dungeon of the ...
Behavior-tracking software firm Amplitude Inc. today announced the launch of AI Feedback, a customer feedback engine using large language model technology that automatically turns raw input into ...
Amplitude delivered better-than-expected results in its Q2 report. The response to its AI agents has been strong so far. Forrester ranked the company as a leader in digital analytics. The big news for ...
AI Agents work 24/7 to analyze user behavior, run experiments, and optimize product experiences so teams can achieve more Resource constraints are a universal pain point for product, marketing, and ...
ENLIGHTED phase 3 study: Interim results of efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) in the treatment of low-grade upper tract urothelial cancer (LG UTUC). This ...
Amplitude provides surgical technologies for lower limb orthopedics Zydus Lifesciences is the buyer The deal is valued at a price of €6.25 per share PAI Partners has entered exclusive talks to sell ...
India's Zydus Lifesciences to buy 86% stake in French medical devices maker India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results